4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Company: Tonix Pharmaceuticals Holding Corp.
Filed: September 28, 2021
Period of Report: September 28, 2021
Accession Number: 0001387131-21-009696

View Document ↗ View on SEC.gov ↗